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The burden of hypertension, a silent killer, continues to increase in low- and middle-income countries. This study evaluated blood
pressure (BP) in healthy adults to determine their risk of developing hypertension and to reduce associatedmorbidity of the disease.
Overall, 182 subjects aged >16 years participated in the study. Systolic (SBP) and diastolic blood pressure (DBP) was measured after
a resting period usingmercury sphygmomanometer. Random blood glucose (RBG) concentration was also determined. Regression
models were used to determine risk of high BP with 𝑝 values < 0.05 indicating statistical difference. Prehypertension was present in
36.8% population and high BP in 31% individuals with hypertensive symptoms. DBP ≥ 90mmHgwas prevalent in the undiagnosed
group, while diabetes comorbidity was detected in only 4 individuals. High BP or diabetes was not detected in those <20 year olds.
Age > 35 years was an independent risk (likelihood ratio: 22.56, 𝑝 < 0.0001); this increases to 26.48 (𝑝 < 0.0001) in the presence
prediabetes and RBG > 100mg/dl. Undiagnosed hypertension rate is high in the study area, and urgent interventions for large scale
screening and management of the disease are required to reduce the burden of hypertension in Nigeria.
1. Introduction
The burden of noncommunicable diseases (NCDs) has
increased in developing countries over the past decade and
majority of deaths occurred in low- and middle-income
countries (LMIC) [1, 2]. About 16 million people die pre-
maturely annually from preventable NCDs, the impact of
which can be lessened by reducing the risk factors associated
with these diseases [3]. Diabetes and hypertension are two
prevalent metabolic and leading risk factors for cardiovas-
cular diseases, which rank the highest among the causes
of mortality associated with noncommunicable diseases in
Africa [3–8]. Diabetes mellitus, a chronic health condition
that causes high blood sugar levels due to poor insulin
production or poor utilization by the body [9], often coexists
with hypertension (a systolic blood pressure ≥ 140mmHg
or diastolic blood pressure ≥ 90mmHg), because they share
common disease mechanisms; one condition exacerbates the
other [10–12] although this may not always be the case [13].
The global incidence of diabetes mellitus increased in the
past few decades from 108 million in 1980 to 422 million
in 2014 [2] and people with uncontrolled hypertension rose
from 600 million in 1980 to nearly 1 billion in 2008 [3, 4].
Thehighest incidence of diabetes and hypertension occurring
in developing countries [2, 14, 15] has been attributed to
population growth, ageing, and modernization [16].
Majority of adults (>25 years of age) are affected with
these conditions and are oblivious of it; this often results in
complications such as cardiovascular diseases, kidney failure,
stroke, blindness, and nerve damage [2, 17–19], thus increas-
ing the risk of deaths attributable to NCDs which is projected
to rise rapidly by 2030 [3, 4, 14]. Diabetes mellitus and
hypertension are often asymptomatic and undetected such
that many people living with these conditions are oblivious of
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it [20]. Diagnosis is usually donewhen pathological and func-
tional damage have progressed, thus resulting in complica-
tions and high death rates attributable to these diseases [3, 4,
6, 7, 10, 21]. Prediabetes (impaired fasting glucose and glucose
tolerance) precedes the onset of diabetes, while raised blood
pressure precedes hypertension; early detection and timely
treatment of diabetes and hypertension are an important
strategy that can be utilized in poor resource countries where
NCD disease burdens are high. Studies have shown that
diabetes and hypertension can be prevented ormanaged with
drugs and lifestyle modification, thus reducing the disease
burden and its sequelae [22–24]. Detection of prediabetes and
prehypertension to determine persons at risk of the diseases
is critical for early management and prevention of these
diseases. Global prevalence of diabetes is 10% and has been
on the increase in LMIC and 40% incidence of hypertension
was reported in 2008 with the highest prevalence occurring
in Sub-Saharan Africa; however, the prevalence varies widely
across countries and regions [4, 5, 8, 25, 26]. In Nigeria, the
reported prevalence of diagnosed diabetes mellitus ranges
between 4.6–25% and 25–54% for hypertension, and there is a
large population of undiagnosed cases [2, 11, 27–31]. In recent
times, there are few studies evaluating the risks and predis-
position to or early detection of hypertension and diabetes
comorbidity especially in community settings in Nigeria and
it has become imperative to reduce the increasing burden
of cardiovascular diseases [32–34]. This study evaluates the
prevalence of prehypertension and the risk of hypertension
in apparently healthy adults living in semiurban communities
in Nigeria where access to robust health care services is
expensive and NCDs prevalence is high. The study was a
cross-sectional survey which evaluated prehypertension or
hypertension in healthy participants aged >16 years.
2. Methods
2.1. Study Area. The study was carried out in two suburban
communities in Ota, southwest Nigeria, in April 2016 where
a voluntary health survey was carried out. Ota is a populous
citywith a population size of over 160,000 residents. Informed
consent was obtained from the participants of the study. The
community leader was sought for permission and ethical
approval was given by Covenant University Health Research
Ethics Committee and local authority.
2.2. Study Population. The inclusion criteria for selecting the
study participants were individuals who aged between 16 and
95 years, were nonpregnant, nondiabetic, or nonhyperten-
sive, and were not under treatment for any of the conditions
in the past two weeks and apparently healthy individuals
who were willing to participate in the study. Persons with
known chronic diseases and those who are ill and on
antihypertensive or antidiabeticmedication or aged ≤15 years
were excluded from the study. Children aged <16 years (𝑛 =
158), pregnant women (𝑛 = 3), and critically ill persons
(𝑛 = 2) were excluded from the evaluation. The power of the
studywas 0.90, with 7.5%margin of error and 95% confidence
limit; the minimum required sample size was 171 persons.
This convenient sample size of ≤200 was used for the study.
2.3. Study Design. The study was a cross-sectional survey,
which evaluated the presence or absence of prediabetes, or
diabetes mellitus and raised blood pressure (prehyperten-
sion) or hypertension onset in healthy adults.
2.4. Clinical Assessment. Age and demographywere enquired
from the participants, using a mercury sphygmomanometer;
BPmeasurements were taken thrice, in persons with high BP;
after a resting period of 15 minutes, the measurement was
done again by the same field worker. Blood glucose concen-
tration was determined in a subpopulation of participants,
from blood obtained from a finger prick; random blood
glucose or fasting blood glucose level was estimated using
Randox Glucometer. The attending physician clerked the
individuals for further enquiries about symptoms or history
of diabetes mellitus or hypertension and drug use.
2.5. Evaluation. Raised blood pressure or prehypertension
was taken to be systolic blood pressure (SBP) of 120–
139mmHgor diastolic blood pressure (DBP) of 80–89mmHg.
Hypertension was defined as SBP ≥ 140mmHg and/or DBP ≥
90mmHg [2, 35]. Prediabetes was defined as random blood
glucose (RBG) of 140–199mg/dl or fasting blood glucose
of 100–125mg/dl. Diabetes mellitus was defined as random
blood glucose level of ≥200mg/dl or fasting blood glucose
of ≥126mg/dl [6]. Others that are not within these categories
were classified as normal.
2.6. Statistical Analysis. Data are expressed as mean ± stan-
dard deviation or proportions and were analyzed using
GraphPad prism version 4 and SPSS version 16. Association
between covariants and hypertension or diabetes was tested
using correlation and regression models; likelihood ratio was
estimated using Cox regression analysis. Chi-square test was
used to compare proportions and 𝑝 values of <0.05 were
taken to indicate statistical difference.
3. Results
Overall, 182 individuals who met the inclusion criteria were
included in the study. There were 141 (77%) females and
16 (8.7%) participants aged ≤20 years in the cohort. The
mean age of the participants was 41.36 years (95% confidence
interval 39.26–43.46, range 16–95 years), mean systolic blood
pressure (SBP) of 119.4mmHg (95% CI 116.3–122.5, range
90–200mmHg), and mean diastolic blood pressure (DBP) of
78.4mmHg (95% CI 76.4–80.3, range 50–120mmHg).
3.1. Prevalence of Prehypertension and Hypertension. Prehy-
pertension was present in 67 (36.8%) individuals from the
cohort of which 72.3% were females and 3 were aged 20–23
years. Systolic blood pressure ≥ 140mmHg was recorded in
29 (15.9%) individuals; 23 (79.3%) of them were females;
SBP of ≥140mmHg was not detected in participants <25
years old. Using standard population distribution of 50.4%
females in Ota, gender adjusted prevalence of hypertension
was 8.2% and 7.25% in females and males, respectively. This
proportion was similar in males and females. Diastolic blood
pressure ≥ 90mmHg was present in 54 individuals (90%
females). Similarly, DBP ≥ 90mmHg was not detected in
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Figure 1: Prevalence of prehypertension and hypertension based
on age in the study cohort. Prehypertension was defined as SBP
120–139mmHg or DBP 80–90mmHg and hypertension as SBP ≥
140mmHg or DBP ≥ 90mmHg.
any participant <25 years. In total, 57 (31%) of the enrolled
individuals had SBP ≥ 140mmHg and/or DBP ≥ 90mmHg,
while 47% of them had both SBP ≥ 140 and DBP ≥ 90mmHg.
Figure 1 shows the age specific prevalence of prehypertension
or hypertension in the cohort.
3.2. Prevalence of Prediabetes and Diabetes. Blood glucose
test was done in a subpopulation of participants (𝑛 =
79). Random blood glucose ≥ 100mg/dl was detected in 45
participants, while prediabetes and diabetes were present in 3
and 4 individuals, respectively. None of the participants aged
<20 years had prediabetes or diabetes.
3.3. Hypertension and Other Comorbidities. All 4 diabetic
individuals also had hypertension comorbidity, while the
3 individuals with prediabetes had prehypertension. Few
individuals in the cohort reported related symptoms such
as headaches, weakness, and palpitations; this group is com-
prised mostly of adults older than 40 years. They were refer-
red for appropriate medical follow-up.
3.4. Risk Assessment for Prehypertension and Hypertension.
There was a significant positive correlation between pre-
hypertension and age > 35 years (likelihood ratio 21.19, 𝑝
< 0.0001) but not gender (likelihood ratio 0.85, 𝑝 = 0.58)
(Table 1). Likewise, there was a significant correlation
between RBG and SBP (𝑟 = 0.22, 𝑝 = 0.04), but not DBP
(𝑟 = 0.18, 𝑝 = 0.10). Prehypertension and blood sugar >
100mg/dl showed no significant correlation (𝑝 = 0.06) but
hypertension was significantly associated with blood sugar
>100mg/dl (likelihood ratio 6.66, 𝑝 = 0.01). The likelihood
ratio for becoming hypertensive in the individuals aged >35
years was 22.56, 𝑝 < 0.0001. This increases to 26.48 (odds
ratio 8.72, 95% CI 3.45–22.02, 𝑝 < 0.0001) in the presence
of prediabetes. Figures 2(a) and 2(b) show the plots of age
and SBP (𝑟 = 0.48, 𝑝 < 0.0001) or DBP (𝑟 = 0.36, 𝑝 <
0.0001), respectively, and Figure 3 shows regression plots for
hypertensive and prehypertensive individuals aged <70 years
with similar slope and interval in the two groups.
3.5. Symptoms. Although the study participants appeared
healthy, frequently reported symptoms experienced in the
past few weeks to months include palpitations, weakness,
chest pain, and headaches.
4. Discussion
World Health Organization identified the African region as
having the highest burden of hypertension, estimated at 46%
in >25 year olds [3]. Hypertension as well as diabetes mellitus
contributes significantly to the burden of noncommunicable
diseases globally; about three-quarters of NCD deaths occur
in low- andmiddle-income countries [3]. Africa bears higher
disease burdens due to poor preventive and expensive health
schemes and genetic susceptibilities to some diseases. In our
cohort, only 31.9% individuals had blood pressurewithin nor-
mal range, and 91.1% had blood sugar concentration within
normal range. Similar proportions of male and females in
this setting presented with hypertension; other studies have
reported varying gender proportions in studies carried out in
Nigeria [32]. A third of our population had an undiagnosed
underlying condition (31.3% were hypertensive and 5% were
diabetic), and a similar proportion had prehypertension or
prediabetes (36.8% and 3.4%, resp.). These rates fall within
range from reported studies within and outside Nigeria [26,
28, 30, 36].
Predictions that about 75% of the world hypertensive
populationwill emerge fromdeveloping countries by 2025 [4]
is imminent. With Nigeria’s population of over 200 million
people, indeed there is a high population with undetected
emerging burden of hypertension and reports have also
shown that the highest number of people with diabetes
and impaired fasting glucose lives in Africa [3, 15]. This
population is at increased risk for cardiovascular disease.
Hypertension and diabetes comorbidity rate of 10.5% was
low in this population. Our study detected only 4 individuals
with prediabetes who were also hypertensive in this cohort. It
would appear that comorbidity of hypertension and diabetes
or the preconditions are uncommon in this setting.
Regional variation in the prevalence of diabetes and
hypertension and comorbidities due to cultural and lifestyle
differences, level of awareness, and socioeconomic factors
such as level of income and access to affordable health care
is well established. The prevalence of diabetes in our study
was very low; however, it is similar to rates of 3% in eastern
Nigeria [31]. For hypertension, our study reported higher rate
than another study [37], where a rate of 9.7% was diagnosed
in southwest Nigeria, but similar to 37.8% rate in a clinic
population reported in southern [11] and eastern Nigeria
[28, 34]. Our findings are not significantly disparate with
reports of other studies from Nigerian population as well as
other African countries [5, 25, 32, 34, 37–41]. This finding
calls for routine measures and intervention to improve case
detection and diagnosis of hypertension to reduce the risk of
progression to complications and associated deaths.
There was a strong correlation of age with prediabetes
and prehypertension. Usually, these conditions precede the
disease; although not all persons with the preconditions
will develop the disease, they are implicated in developing
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Figure 2: Scatter plots showing the distribution of systolic (a) (𝑟 = 0.48, 𝑝 < 0.0001) and diastolic (b) blood pressure with age in the study
cohort (𝑟 = 0.36, 𝑝 < 0.0001).
Table 1: Risk assessment of prehypertension and hypertension in the cohort.
Covariants Prehypertensionodds ratio (95% CI)
Hypertension
odds ratio (95% CI) 𝑝 value
Age (years)
>35 4.49 (2.32–8.68) 6.34 (2.66–15.14)
<0.0001
≤35 1 1
RBG (mg/dl)
≥100 0.39 (0.14–1.08)∗ 3.32 (1.27–8.63) 0.01
<100 1
Gender
Male 0.85 (0.39–1.68) 0.75 (0.36–1.57)
>0.46
Female 1
CI: confidence interval; ∗𝑝 = 0.06; RBG: random blood glucose.
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Figure 3: Comparison of regression plots of systolic blood pressure
(SBP) and age in prehypertensive (blue dashed line), hypertensive
(red dashed line), and all participants (black solid line) aged <60
years in the study cohort. Comparison of slopes: 𝑡 = 0.235, 𝑝 =
0.816; comparison of intercepts: 𝑡 = 0.002, 𝑝 = 0.999; test of
coincidence, 𝐹 = 25.365 𝑝 < 0.0001.
complications of the disease such as coronary heart disease
and ischemic and hemorrhagic stroke [3, 19, 36]. Irrespective
of lifestyle, screening and management of these diseases
should be advocated in the adult age group. The likelihood
for developing hypertension in prehypertensive population is
high in the age group ≥35 years and consequences remain the
same. NCDs caused 38 million premature deaths in 2012 and
it is projected to increase to 52 million by year 2030 [3]; it is
apparent that the undiagnosed population with hypertension
and prehypertension of 68.1% will significantly increase soon
and urgent interventions to reduce this emerging burden
will help reduce morbidity and mortality caused by NCDs
in LMIC. It is exigent to continue to detect the undiagnosed
population and monitor trends and disease progress in
affected persons for effective reduction of these public health
problems.
Early detection and management of population with
predisposing factors or the disease can reduce the risk of
cardiovascular diseases [22–24]; however, regular screening
for prehypertension or prediabetes or its knowledge as an
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effective prevention measure is limited across Nigeria. In
a population of hypertensives, 18% with prediabetes were
detected in an African study [39] and 1.1% with prediabetes
in eastern Nigeria [33]. In our population, a rate of 35.7%
prehypertension was recorded in the present study. Predia-
betes often precedes diabetes and the risk of progression to
diabetes especially in hypertensive individuals [10, 13, 39].
Undiagnosed diabetes can progress to development of com-
plications because these conditions are often asymptomatic.
The implication of undiagnosed population in Nigeria is that
if not managed, they will in the next few years contribute
an increase to the already high burden of morbidity and
mortality associated with NCDs in LMIC [3].
The study participants generally comprised adult farmers,
traders, and low income semiurban dwellers who practice
more of indigenous culture, thus a presumed healthy lifestyle.
Causes of these diseases are multifactorial including older
age, lifestyle, diet, and underlying genetic factors, which
are modifiable by environmental and other factors for the
development of either hypertension or diabetes [42]. There
are limitations for the reported study; questionnaires were
not given to the participants to harvest lifestyle or social
status that could be assessed as covariants or determinants
of the observed BP and blood sugar measurements. Our
study did not also evaluate lipid profiles or other biochemical
determinants that predispose one to cardiovascular diseases.
Previous studies have reported obesity, dyslipidemia, seden-
tary lifestyle, and high alcohol consumption as some impor-
tant attributable risk for the development of cardiovascular
diseases in Nigeria [27, 37, 43, 44]. In this population, genetic
risk factors were not determined; thus, further studies are
required in this area to better predict persons at higher
risks of the cardiovascular diseases and preventive strate-
gies.
The high rate of prehypertension in this population
supports predictions of future increase in prevalence of
NCDs in LMICs in the future [3, 4, 14, 40]. Caution is
required in the interpretation of the study outcomes, gender
adjusted prevalence indicates a similar prevalence of risk of
cardiovascular diseases in the area; this however is contrary
to other reports of a variable prevalence of hypertension
based on gender [32, 43]. Our study findings buttress the fact
that there is need for urgent intervention for the emerging
burden of NCDs especially when the individuals are in
the prehypertensive stage. Figure 3 shows a similar pattern
of regression (similar slope and intercept) in hypertensive
and prehypertensive individuals although the lines appear
almost parallel. If no actions are taken in this population, the
imminent is bound to happen.
In conclusion, our findings indicate a low prevalence of
prehypertension, prediabetes, and a high undetected popu-
lationwith cardiovascular diseases in the study area especially
in the adult population. There were no hypertensive or
diabetic persons aged <25 years, suggesting that early onset
of diabetes mellitus or hypertension is not common in this
region. Studies have reported effective reduction in cardio-
vascular diseases and outcomes of treatment in persons that
were managed early [23, 24, 45]. Thus, regular screening in
this age group is also advocated especially in individuals with
genetic susceptibility to the disease which can be detected
early.
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